GALLIDERMIN TO TREAT INFECTIONS OF THE RESPIRATORY TRACT
摘要
The present invention lies in the field of the treatment and prophylaxis of infectious diseases. It relates to the prophylaxis and treatment of bacterial infections of the respiratory tract caused by gram-positive bacteria or other susceptible bacterial pathogens in a patient, comprising the lantibiotic Gallidermin or a pharmaceutically active variant thereof as active substance, and related subject matters.